STOCK TITAN
  1. Home
  2. Sec-filings
  3. RXRX
  4. [144] RECURSION PHARMACEUTICALS, INC. SEC Filing

Recursion Pharmaceuticals (NASDAQ: RXRX) ex-director lines up $255K sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

RECURSION PHARMACEUTICALS, INC. (RXRX) received a Rule 144 notice covering planned sales of 75,000 Class A shares held for the account of former director Christopher C. Gibson. The shares are held at Fidelity Brokerage Services LLC, with an aggregate market value of $255,000.00 and are listed on NASDAQ. The notice also details extensive Class A share sales during the prior three months by Gibson, Lahwran-3 LLC, and the Gibson Family Trust, entities for which Gibson is an authorized individual, trustee, or account stakeholder.

Positive

  • None.

Negative

  • None.
Shares to be sold 75,000 shares Planned Rule 144 sale of Class A common stock for account of Christopher C. Gibson
Aggregate market value of planned sale $255,000.00 Estimated market value of 75,000 Class A shares to be sold
CUSIP / security identifier 535342170 Identifier listed for Class A common stock in the securities information section
Single large prior sale 340,440 shares; $1,089,541.29 Class A shares sold by Christopher C. Gibson on 06/18/2026
Prior sale example 100,000 shares; $390,028.58 Class A shares sold by Christopher C. Gibson on 07/07/2026
Trust sale example 50,000 shares; $195,014.41 Class A shares sold by Gibson Family Trust on 07/07/2026
LLC sale example 186,000 shares; $706,094.96 Class A shares sold by Lahwran-3 LLC on 07/09/2026
Date of notice 08/20/2026 Filing date stated for the Rule 144 notice
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Founders Shares financial
"Class A | 04/20/2021 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
attorney-in-fact regulatory
"as attorney-in-fact for Christopher C. Gibson"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing mean for RECURSION PHARMACEUTICALS, INC. (RXRX)?
The filing reports planned sales of 75,000 Class A shares of RXRX stock under Rule 144 for former director Christopher C. Gibson. It discloses his intent to sell and summarizes related sales in the prior three months, but does not change company operations.

How many RXRX shares is Christopher C. Gibson planning to sell under this Form 144?
The notice covers a planned sale of 75,000 Class A shares of RECURSION PHARMACEUTICALS, INC. These are identified as founders shares originally acquired as compensation from the issuer on April 20, 2021, and held at Fidelity Brokerage Services LLC.

What is the approximate value of the RXRX shares to be sold under this Form 144?
The planned 75,000 Class A shares have an aggregate market value of $255,000.00. This value is stated in the Form 144 securities information section and reflects the approximate market value used for the notice, not a guaranteed sale price.

Who is the selling security holder in the RXRX Form 144 and what is his role?
The selling holder is Christopher C. Gibson, described as a former director of RECURSION PHARMACEUTICALS, INC. The filing also notes sales by Lahwran-3 LLC and the Gibson Family Trust, for which Gibson is an authorized individual, trustee, or account stakeholder.

What prior RXRX share sales are disclosed in this Form 144 filing?
The filing lists multiple Class A share sales over the past three months, including a sale of 340,440 shares for $1,089,541.29 on June 18, 2026, plus numerous 40,000–100,000 share transactions by Gibson, Lahwran-3 LLC, and the Gibson Family Trust with stated dollar amounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR